Establishing a CD8 + T cell–mediated immune correlate of protection in HIV disease is crucial
to the development of vaccines designed to generate cell-mediated immunity. Historically, …

INTRODUCTION Many patients with coronavirus disease 2019 (COVID-19), caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, present with severe …

INTRODUCTION Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA
vaccines are highly effective at preventing infection and especially severe disease. However, …

T cell exhaustion often occurs during chronic infection and prevents optimal viral control. The
molecular pathways involved in T cell exhaustion remain poorly understood. Here we show …

Flow cytometric detection of antigen-specific CD8+ T cells has previously been limited to
MHC-class I tetramer staining or intracellular cytokine production, neither of which measure the …

mRNA vaccines for SARS-CoV-2 have been authorized for emergency use. Despite their
efficacy in clinical trials, data on mRNA vaccine–induced immune responses are mostly limited …

HIV infection is associated with the progressive loss of CD4 + T cells through their destruction
or decreased production 1 , 2 . A central, yet unresolved issue of HIV disease is the …

SARS-CoV-2 messenger RNA vaccination in healthy individuals generates immune
protection against COVID-19. However, little is known about SARS-CoV-2 mRNA vaccine-induced …

Virus-specific CD8 + T-cell responses play a pivotal role in limiting viral replication. Alterations
in these responses, such as decreased cytolytic function, inappropriate maturation, and …

SARS-CoV-2 mRNA vaccines have shown remarkable clinical efficacy, but questions
remain about the nature and kinetics of T cell priming. We performed longitudinal antigen-specific …